Venous thromboembolism in children: Rivaroxaban found effective and safe even with extended use

Venous thromboembolism (VTE) is a life-threatening complication in children with serious underlying conditions such as heart defects or cancer. Treatment or prevention of thrombosis poses an additional challenge in everyday clinical practice. A therapy using the active ingredient rivaroxaban specifically tailored to children was successfully tested for the first time in 2020.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup